Document Detail

A biocatalytic hydrogenation of carboxylic acids.
MedLine Citation:
PMID:  23139934     Owner:  NLM     Status:  Publisher    
The hyperthermophile Pyrococcus furiosus catalyses the hydrogenation of a broad range of carboxylic acids selectively to the corresponding primary alcohols. Other functional groups such as isolated C[double bond, length as m-dash]C-double bonds are not touched. The chemoselectivity of the carboxylate reduction may be directed towards aldehydes by simple medium engineering.
Yan Ni; Peter-Leon Hagedoorn; Jian-He Xu; Isabel W C E Arends; Frank Hollmann
Related Documents :
12434404 - Polymorphism of roxifiban.
23697644 - 7-(dimethylamino)coumarin-3-carbaldehyde and its phenylsemicarbazone: tict excited stat...
9040104 - Polymorphism of sulindac: isolation and characterization of a new polymorph and three n...
20533554 - Solid-state forms of zoledronic acid: polymorphism in hydrates.
11671324 - Hydrolysis of a model for the 5'-cap of mrna by dinuclear copper(ii) and zinc(ii) compl...
17489584 - Rational design of a covalently tethered dinuclear [mnii(n3o2)cl(oh2)]2(2+) macrocyclic...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-9
Journal Detail:
Title:  Chemical communications (Cambridge, England)     Volume:  -     ISSN:  1364-548X     ISO Abbreviation:  Chem. Commun. (Camb.)     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-9     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610838     Medline TA:  Chem Commun (Camb)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Delft University of Technology, Department of Biotechnology, Julianalaan 136, 2628BL Delft, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Overcoming the solvation shell during the crystallisation of diatrizoic acid from dimethylsulfoxide.
Next Document:  A multimodal, ?-amyloid-targeted contrast agent.